Wungki Park, Assistant Attending at Memorial Sloan Kettering Cancer Center and Assistant Professor of Medicine at Weill Cornell Medicine, shared a post on X:
“Thrilled to join this Powerhouse session at ESMO GI 2026.
Incredible to witness so many advances in pancreatic cancer presented on one stage and to share it with leaders including Brian Wolpin, Nilo Azad, Eric Van Cutsem and Teresa Macarulla.
The era of K/RAS inhibitors, rational combinations and biomarker-driven therapeutics is here. Unprecedented response rates in this disease ever!
We keep learning from the positive and negative work.
Search and REsearch!
I really appreciate the team so dedicated to learn the science from the GLEAM trial.
We’re finally moving the field forward.
The future of pancreatic cancer has never looked brighter.”
Other articles about ESMO GI 2026 on OncoDaily.
